Total Ankle Replacement Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
The total ankle replacement market is majorly driven by the aging population and the increasing prevalence of rheumatoid and osteoarthritis diseases. According to the Centers for Disease Control and Prevention, with the aging US population, the prevalence of doctor-diagnosed arthritis is expected to increase and by 2040, an estimated 78.4 million (25.9% of the projected total adult population) adults aged 18 years and above are likely to have doctor-diagnosed arthritis.
In the United States, osteoarthritis affects 14% of adults aged 25 years and above and 34% of those aged 65 years and above. It is also estimated that 1.5 million adults are suffering from rheumatoid arthritis, while 3.0 million adults are suffering from gout in the country. An estimated 2, 94,000 children of age 18 years or below (or one in every 250 children) have been diagnosed with arthritis or another rheumatologic condition in the United States. Hence, the increasing number of cases of osteoarthritis and rheumatoid arthritis in adults and children is likely to increase the demand for total ankle replacement surgeries.
The HINTEGRA total ankle replacement (TAR) was designed by Beat Hintermann, Greta Dereymaeker, Ramon Viladot, and Patrice Diebold, in 2000. It is an unconstrained, three-component system that provides inversion-eversion stability. The HINTEGRA TAR consists of two metallic components and an ultrahigh-density polyethylene mobile bearing, which provide axial rotation and normal flexion-extension mobility.
Furthermore, TAR has evolved as a valuable gold standard treatment option for patients with end-stage ankle osteoarthritis, which generally affects the aging population. Hence, owing to the higher preference of these devices and the rapidly aging population, the market is expected to witness rapid growth in the forecast period.
The United States dominates the total ankle replacement market, owing to high awareness among the people and availability of reimbursements. However, Asia-Pacific is predicted to be the emerging region in the total ankle replacement market during the forecast period, due to increasing healthcare expenditure and rising awareness regarding innovative medical technologies.
Globally, only a few major players control the major share of the market studied, which is primarily due to the need for high technological expertise in the development of devices and regulatory challenges involved in the development of total ankle replacement devices. Key market players include Johnson & Johnson, Integra LifeSciences Corporation, Stryker Corporation, Wright Medical Group Inc., MatOrtho, Zimmer Biomet, Exactech Inc., and Corin Group.